Danaher Net Current Debt 2010-2025 | DHR

Danaher annual/quarterly net current debt history and growth rate from 2010 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
  • Danaher net current debt for the quarter ending March 31, 2025 was $1M, a 98.53% decline year-over-year.
  • Danaher net current debt for the twelve months ending March 31, 2025 was $-2.641B, a 68.54% increase year-over-year.
  • Danaher annual net current debt for 2024 was $-1.669B, a 2.64% increase from 2023.
  • Danaher annual net current debt for 2023 was $-1.626B, a 3.67% decline from 2022.
  • Danaher annual net current debt for 2022 was $-1.688B, a 174.53% decline from 2021.
Danaher Annual Net Current Debt
(Millions of US $)
2024 $-1,669
2023 $-1,626
2022 $-1,688
2021 $2,265
2020 $4,033
2019 $2,802
2018 $-508
2017 $1,114
2016 $760
2015 $3,511
2014 $-103
2013 $-763
2012 $196
2011 $854
2010 $N/A
2009 $-446
Sector Industry Market Cap Revenue
Medical Medical Services $137.452B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $85.620B 11.05
CVS Health (CVS) United States $80.443B 10.00
Cencora (COR) United States $56.509B 19.66
Natera (NTRA) United States $21.868B 0.00
DiDi Global (DIDIY) China $21.650B 32.86
BioMerieux (BMXMF) France $15.890B 0.00
Solventum (SOLV) United States $12.848B 13.60
EUROFINS SCIENT (ERFSF) Luxembourg $12.645B 0.00
CochLear (CHEOY) Australia $11.378B 0.00
ICON (ICLR) Ireland $10.802B 10.04
Revvity (RVTY) United States $10.730B 18.47
Viatris (VTRS) United States $10.223B 3.51
Doximity (DOCS) United States $10.051B 46.53
HealthEquity (HQY) United States $8.975B 39.30
Avantor (AVTR) United States $8.961B 13.02
Medpace Holdings (MEDP) United States $8.797B 23.36
Sonic Healthcare (SKHHY) Australia $8.301B 0.00
Charles River Laboratories (CRL) United States $6.802B 13.33
Amplifon S.p.A (AMFPF) Italy $4.966B 27.18
BrightSpring Health Services (BTSG) United States $4.121B 38.15
Bausch + Lomb (BLCO) Canada $4.065B 23.96
Sotera Health (SHC) United States $3.486B 19.81
Alignment Healthcare (ALHC) United States $3.035B 0.00
Surgery Partners (SGRY) United States $2.984B 38.80
Concentras Parent (CON) United States $2.776B 16.04
Organon (OGN) United States $2.454B 2.61
Ardent Health Partners (ARDT) United States $2.084B 8.88
GeneDx Holdings (WGS) United States $2.078B 80.01
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.884B 41.47
PACS (PACS) United States $1.554B 0.00
GoodRx Holdings (GDRX) United States $1.407B 28.14
Teladoc Health (TDOC) United States $1.239B 0.00
Pediatrix Medical (MD) United States $1.186B 9.02
Establishment Labs Holdings (ESTA) $1.061B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
CareDx (CDNA) United States $0.971B 15.16
Agilon Health (AGL) United States $0.940B 0.00
Nutex Health (NUTX) United States $0.825B 12.46
AMN Healthcare Services Inc (AMN) United States $0.783B 7.33
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.620B 4.18
LifeMD (LFMD) United States $0.575B 0.00
InnovAge Holding (INNV) United States $0.548B 0.00
Enhabit (EHAB) United States $0.528B 43.46
SBC Medicals (SBC) United States $0.501B 0.00
Auna S.A (AUNA) Luxembourg $0.491B 11.07
Sonida Senior Living (SNDA) United States $0.465B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.429B 0.00
Oncology Institute (TOI) United States $0.286B 0.00
Performant Healthcare (PHLT) United States $0.254B 0.00
Beauty Health (SKIN) United States $0.208B 0.00
DocGo (DCGO) United States $0.151B 24.67
KindlyMD (KDLY) United States $0.150B 0.00
KindlyMD (NAKA) United States $0.111B 0.00
Basel Medical Group (BMGL) Singapore $0.094B 0.00
So-Young (SY) China $0.091B 0.00
OncoCyte (OCX) United States $0.088B 0.00
Sera Prognostics (SERA) United States $0.072B 0.00
Ascend Wellness Holdings (AAWH) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Pheton Holdings (PTHL) China $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
ModivCare (MODV) United States $0.028B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00